
|Articles|June 22, 2009
FDA's Keith Webber on Setting Specifications
Author(s)BioPharm International Editors
Advertisement
FDA´s Keith Webber on Setting Specifications
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Top 10 BioPharm International Articles of 2025
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
4
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
5




